Company Description
Leidos Holdings, Inc. is a holding company, which engages in the provision of scientific, engineering and information technology services and solutions in the areas of defense, intelligence, civil and health markets. It operates through the following three segments: Defense Solutions, Civil, and Hea...
Leidos Holdings, Inc. is a holding company, which engages in the provision of scientific, engineering and information technology services and solutions in the areas of defense, intelligence, civil and health markets. It operates through the following three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment focuses on deploying agile, cost-effective solutions to meet the ever-changing missions of the company's customers in areas of intelligence surveillance and reconnaissance, enterprise IT and integrated systems and cybersecurity and global services. The Civil segment focuses on seamlessly integrating and protecting physical, digital and data domains. The Health segment offers solutions to federal and commercial customers that are responsible for the health and wellbeing of people worldwide including service members and veterans. The company was founded by John Robert Beyster on February 3, 1969 and is headquartered in Reston, VA.
Valuation
P/E Current
23.72
P/E Ratio (with extraordinary items)
25.67
P/E Ratio (without extraordinary items)
21.63
Price to Sales Ratio
1.30
Price to Book Ratio
4.11
Price to Cash Flow Ratio
14.54
Enterprise Value to EBITDA
14.74
Enterprise Value to Sales
1.55
Total Debt to Enterprise Value
0.20
Efficiency
Revenue/Employee
326,294.00
Income Per Employee
19,618.00
Receivables Turnover
6.14
Total Asset Turnover
1.19
Liquidity
Current Ratio
1.16
Quick Ratio
1.16
Cash Ratio
0.31
Profitability
Gross Margin
13.95
Operating Margin
8.10
Pretax Margin
7.81
Net Margin
6.01
Return on Assets
7.15
Return on Equity
19.85
Return on Total Capital
13.52
Return on Invested Capital
10.24
Capital Structure
Total Debt to Total Equity
100.91
Total Debt to Total Capital
50.23
Total Debt to Total Assets
35.66
Long-Term Debt to Equity
95.25
Long-Term Debt to Total Capital
47.41
Officers and Executives
Name | Age | Officer Since | Title |
---|---|---|---|
Mr. Roger A. Krone | 62 | 2014 | Chief Executive Officer & Director |
Mr. James Corbett Reagan | 61 | 2015 | Chief Financial Officer & Executive VP |
Mr. James F. Carlini | - | - | Chief Technology Officer |
Mr. Peter ODonoghue | - | - | Chief Technology Officer |
Dr. Donald Kosiak | - | 2016 | Chief Medical Officer |
Insider Actions
01/07/2021 |
Miriam E. John Director |
337 | Award at $103.99 per share. | 35,044 |
12/31/2020 |
Roger A. Krone CEO; Director |
367 | Award at $0 per share. | 0 |
12/31/2020 |
Harry M. Jansen Kraemer Director |
377 | Award at $0 per share. | 0 |
12/31/2020 |
James Corbett Reagan EVP, Chief Financial Officer |
251 | Award at $0 per share. | 0 |
12/31/2020 |
Miriam E. John Director |
231 | Award at $0 per share. | 0 |
12/31/2020 |
James R. Moos Group President |
7 | Award at $0 per share. | 0 |
12/31/2020 |
Christopher R. Cage SVP and Corporate Controller |
72 | Award at $0 per share. | 0 |
12/31/2020 |
Jerald S. Howe Executive VP & General Counsel |
16 | Award at $0 per share. | 0 |
12/31/2020 |
Frank Kendall Director |
16 | Award at $0 per share. | 0 |
12/01/2020 |
Noel Brown Williams Director |
11,685 | Derivative/Non-derivative trans. at $28.84 per share. | 336,995 |
11/23/2020 |
Christopher R. Cage SVP and Corporate Controller |
1,660 | Derivative/Non-derivative trans. at $100.37 per share. | 166,614 |
11/23/2020 |
Christopher R. Cage SVP and Corporate Controller |
3,382 | Derivative/Non-derivative trans. at $27.23 per share. | 92,091 |
11/17/2020 |
David G. Fubini Director |
1,411 | Disposition at $99.59 per share. | 140,521 |
11/17/2020 |
David G. Fubini Director |
5,500 | Disposition at $98.41 per share. | 541,255 |
11/13/2020 |
Roger A. Krone CEO; Director |
828 | Derivative/Non-derivative trans. at $94.16 per share. | 77,964 |
11/13/2020 |
Roger A. Krone CEO; Director |
1,256 | Derivative/Non-derivative trans. at $94.16 per share. | 118,264 |
11/13/2020 |
David G. Fubini Director |
3,233 | Derivative/Non-derivative trans. at $94.16 per share. | 304,419 |
11/13/2020 |
David G. Fubini Director |
10,144 | Derivative/Non-derivative trans. at $30 per share. | 304,320 |
11/10/2020 |
James R. Moos Group President |
792 | Gift at $0 per share. | 0 |
11/09/2020 |
Gary Stephen May Director |
500 | Disposition at $95.95 per share. | 47,975 |
11/06/2020 |
Gerry Fasano Group President |
7,535 | Derivative/Non-derivative trans. at $91.4 per share. | 688,699 |
11/06/2020 |
Robert S. Shapard Director |
3,332 | Derivative/Non-derivative trans. at $91.4 per share. | 304,544 |
11/06/2020 |
Gerry Fasano Group President |
9,841 | Derivative/Non-derivative trans. at $53.54 per share. | 526,887 |
11/06/2020 |
Robert S. Shapard Director |
10,144 | Award at $30 per share. | 304,320 |
10/07/2020 |
Miriam E. John Director |
393 | Award at $89.01 per share. | 34,980 |
MarketWatch News on LDOS
-
13 Cheap Stocks That Could Offer More Shareholder Returns in 2021
- Barron's Online
-
Leidos Holdings Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
Leidos Holdings Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
Leidos Holdings Inc. stock rises Wednesday, outperforms market
- MarketWatch Automation
-
Leidos Holdings Inc. stock outperforms competitors on strong trading day
- MarketWatch Automation
-
Leidos Holdings Inc. stock falls Monday, underperforms market
- MarketWatch Automation
-
Leidos Holdings Inc. stock outperforms competitors on strong trading day
- MarketWatch Automation
-
Leidos Holdings Inc. stock falls Thursday, underperforms market
- MarketWatch Automation
-
Leidos Holdings Inc. stock rises Wednesday, outperforms market
- MarketWatch Automation
-
Leidos Holdings Inc. stock rises Tuesday, still underperforms market
- MarketWatch Automation
-
Leidos Holdings Inc. stock falls Monday, underperforms market
- MarketWatch Automation
-
Leidos Holdings Inc. stock falls Friday, underperforms market
- MarketWatch Automation
-
Leidos Holdings Inc. stock rises Tuesday, still underperforms market
- MarketWatch Automation
-
Leidos Holdings Inc. stock rises Monday, outperforms market
- MarketWatch Automation
-
Leidos Holdings Inc. stock outperforms competitors on strong trading day
- MarketWatch Automation
-
Leidos Holdings Inc. stock outperforms competitors on strong trading day
- MarketWatch Automation
-
Leidos Holdings Inc. stock underperforms Wednesday when compared to competitors
- MarketWatch Automation
-
Leidos Holdings Inc. stock falls Tuesday, still outperforms market
- MarketWatch Automation
-
Leidos Holdings Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
Leidos Holdings Inc. stock outperforms competitors on strong trading day
- MarketWatch Automation
- Loading more headlines...
Other News on LDOS
-
Space names take off as ARK Invest jumps into sector with ETF
- Seeking Alpha
-
Leidos Holdings: Strong Enough
- Seeking Alpha
-
Leidos to Acquire 1901 Group for $215M
- Seeking Alpha
- Loading more headlines...